Zeo ScientifiX, Inc.
Zeo ScientifiX, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines. Its lead product candidate is Zofin, an acellular biologic therapeutic derived from perinatal sources, which is in Phase I/II clinical trial to treat COVID-19, chronic obstructive pulmonary disease, osteoarth… Read more
Zeo ScientifiX, Inc. (ZEOX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of October 2025: 0.269x
Based on the latest financial reports, Zeo ScientifiX, Inc. (ZEOX) has a cash flow conversion efficiency ratio of 0.269x as of October 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-383.00K) by net assets ($-1.42 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zeo ScientifiX, Inc. - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Zeo ScientifiX, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zeo ScientifiX, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zeo ScientifiX, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cloudastructure, Inc. Class A Common Stock
NASDAQ:CSAI
|
-0.199x |
|
Remsons Industries Limited
NSE:REMSONSIND
|
0.250x |
|
Rapid Dose Therapeutics Corp
PINK:RDTCF
|
0.032x |
|
The Investment Trust Of India Limited
NSE:THEINVEST
|
-0.402x |
|
Galileo Mining Ltd
AU:GAL
|
-0.002x |
|
Ion Video Ltd
AU:IOV
|
1.223x |
|
Vraj Iron and Steel Ltd
NSE:VRAJ
|
0.071x |
|
NORTHERN FREEGOLD
F:8N6
|
-0.179x |
Annual Cash Flow Conversion Efficiency for Zeo ScientifiX, Inc. (2020–2025)
The table below shows the annual cash flow conversion efficiency of Zeo ScientifiX, Inc. from 2020 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-10-31 | $-1.42 Million | $-718.00K | 0.505x | -42.48% |
| 2024-10-31 | $-1.65 Million | $-1.45 Million | 0.877x | -50.45% |
| 2023-10-31 | $-1.24 Million | $-2.20 Million | 1.770x | +205.61% |
| 2022-10-31 | $1.89 Million | $-3.17 Million | -1.676x | -266.71% |
| 2021-10-31 | $-2.67 Million | $-2.68 Million | 1.006x | -22.78% |
| 2020-10-31 | $-1.39 Million | $-1.81 Million | 1.302x | -- |